Discontinued — last reported Q4 '21
Labcorp Holdings Other countries — Revenue remained flat by 0.0% to $244.10M in Q4 2021 compared to the prior quarter. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher revenues indicate strong demand and successful service delivery in international regions, while declining revenues may signal competitive pressure or economic headwinds.
This metric captures the total gross revenue generated from clinical laboratory services and diagnostic testing provided...
Growth rates are typically compared against regional healthcare spending trends and the competitive landscape of local diagnostic providers.
lh_segment_other_countries_revenues| FY'21 | |
|---|---|
| Value | $976.40M |